<DOC>
	<DOC>NCT01823705</DOC>
	<brief_summary>The purpose of this feasibility study is to provide safety data on the implantable Exilis gastric electrical stimulation (GES) system, to individually adjust stimulation parameters to levels that are comfortable for implanted subjects during chronic daily treatment, and to collect data on acute gastrointestinal function and food intake responses to GES during in-clinic testing.</brief_summary>
	<brief_title>Gastric Electrical Stimulation (GES) for the Treatment of Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>Adults ages 2164 with BMI of 4045 kg/m^2 or BMI 3539.9 kg/m^2 with at least one obesityrelated comorbidity, who have failed prior nonsurgical weight loss attempts, and have been within 5% of their current weight for at least one year. If diabetic, subject has noninsulindependent type 2 diabetes mellitus diagnosed within the last 7 years, and has an HbA1c level less than 8%. If female and of childbearing age, subject is not pregnant or lactating and is willing to use effective contraception for the duration of the study. Subject is willing and able to complete scheduled study visits, complete online lifestyle educational modules, and complete required procedures. Subject has a history of medical, surgical, or psychiatric conditions that, in the opinion of the Investigators, would limit study participation or contraindicate implantation of the Exilis GES system. Examples includes cardiac abnormalities contraindicating surgical anesthesia, prior gastrointestinal surgery, gastrointestinal motility disorders, inflammatory bowel disease, a history of eating disorders, anticipated future need for magnetic resonance imaging, or allergies to food ingredients in study test meals.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>